These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 9044310)

  • 1. Administration of AGEs in vivo induces extracellular matrix gene expression.
    Striker LJ; Striker GE
    Nephrol Dial Transplant; 1996; 11 Suppl 5():62-5. PubMed ID: 9044310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Administration of AGEs in vivo induces genes implicated in diabetic glomerulosclerosis.
    Yang CW; Vlassara H; Striker GE; Striker LJ
    Kidney Int Suppl; 1995 Jun; 49():S55-8. PubMed ID: 7674596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced glycation end products up-regulate gene expression found in diabetic glomerular disease.
    Yang CW; Vlassara H; Peten EP; He CJ; Striker GE; Striker LJ
    Proc Natl Acad Sci U S A; 1994 Sep; 91(20):9436-40. PubMed ID: 7937785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aminoguanidine ameliorates overexpression of prosclerotic growth factors and collagen deposition in experimental diabetic nephropathy.
    Kelly DJ; Gilbert RE; Cox AJ; Soulis T; Jerums G; Cooper ME
    J Am Soc Nephrol; 2001 Oct; 12(10):2098-2107. PubMed ID: 11562408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of transforming growth factor-beta 1 mRNA is associated with up-regulation of glomerular tenascin and laminin gene expression in nonobese diabetic mice.
    Yang CW; Hattori M; Vlassara H; He CJ; Carome MA; Yamato E; Elliot S; Striker GE; Striker LJ
    J Am Soc Nephrol; 1995 Feb; 5(8):1610-7. PubMed ID: 7538809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chrysin Inhibits Advanced Glycation End Products-Induced Kidney Fibrosis in Renal Mesangial Cells and Diabetic Kidneys.
    Lee EJ; Kang MK; Kim DY; Kim YH; Oh H; Kang YH
    Nutrients; 2018 Jul; 10(7):. PubMed ID: 29987200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Receptor-specific increase in extracellular matrix production in mouse mesangial cells by advanced glycosylation end products is mediated via platelet-derived growth factor.
    Doi T; Vlassara H; Kirstein M; Yamada Y; Striker GE; Striker LJ
    Proc Natl Acad Sci U S A; 1992 Apr; 89(7):2873-7. PubMed ID: 1313571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roles of advanced glycation end-products in the progression of diabetic nephropathy.
    Makino H; Shikata K; Kushiro M; Hironaka K; Yamasaki Y; Sugimoto H; Ota Z; Araki N; Horiuchi S
    Nephrol Dial Transplant; 1996; 11 Suppl 5():76-80. PubMed ID: 9044313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Localization of glycated proteins in the glomeruli of patients with diabetic nephropathy.
    Sakai H; Jinde K; Suzuki D; Yagame M; Nomoto Y
    Nephrol Dial Transplant; 1996; 11 Suppl 5():66-71. PubMed ID: 9044311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracellular matrix is modulated in advanced glycation end products milieu via a RAGE receptor dependent pathway boosted by transforming growth factor-β1 RAGE.
    Serban AI; Stanca L; Geicu OI; Munteanu MC; Costache M; Dinischiotu A
    J Diabetes; 2015 Jan; 7(1):114-24. PubMed ID: 24666836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glomerular expression of platelet-derived growth factor (PDGF)-A, -B chain and PDGF receptor-alpha, -beta in human diabetic nephropathy.
    Uehara G; Suzuki D; Toyoda M; Umezono T; Sakai H
    Clin Exp Nephrol; 2004 Mar; 8(1):36-42. PubMed ID: 15067514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advanced glycation end products modulate transcriptional regulation in mesangial cells.
    Iehara N; Takeoka H; Yamada Y; Kita T; Doi T
    Kidney Int; 1996 Oct; 50(4):1166-72. PubMed ID: 8887274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of Advanced Glycation End Products (AGEs) Accumulation by Pyridoxamine Modulates Glomerular and Mesangial Cell Estrogen Receptor α Expression in Aged Female Mice.
    Pereira-Simon S; Rubio GA; Xia X; Cai W; Choi R; Striker GE; Elliot SJ
    PLoS One; 2016; 11(7):e0159666. PubMed ID: 27428057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy.
    Yamamoto T; Nakamura T; Noble NA; Ruoslahti E; Border WA
    Proc Natl Acad Sci U S A; 1993 Mar; 90(5):1814-8. PubMed ID: 7680480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of transforming growth factor beta and vascular endothelial growth factor in diabetic nephropathy in rats by a novel advanced glycation end product inhibitor, OPB-9195.
    Tsuchida K; Makita Z; Yamagishi S; Atsumi T; Miyoshi H; Obara S; Ishida M; Ishikawa S; Yasumura K; Koike T
    Diabetologia; 1999 May; 42(5):579-88. PubMed ID: 10333051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetic nephropathy: molecular analysis of extracellular matrix and clinical studies update.
    Striker GE; Eastman RD; Striker LJ
    Nephrol Dial Transplant; 1996; 11 Suppl 5():58-61. PubMed ID: 9044309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential expression of glomerular extracellular matrix and growth factor mRNA in rapid and slowly progressive glomerulosclerosis: studies in mice transgenic for native or mutated growth hormone.
    Yang CW; Striker GE; Chen WY; Kopchick JJ; Striker LJ
    Lab Invest; 1997 Apr; 76(4):467-76. PubMed ID: 9111509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salvianolic Acid A Protects Against Diabetic Nephropathy through Ameliorating Glomerular Endothelial Dysfunction via Inhibiting AGE-RAGE Signaling.
    Hou B; Qiang G; Zhao Y; Yang X; Chen X; Yan Y; Wang X; Liu C; Zhang L; Du G
    Cell Physiol Biochem; 2017; 44(6):2378-2394. PubMed ID: 29262395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advanced glycation end products decrease mesangial cell MMP-7: a role in matrix accumulation in diabetic nephropathy?
    McLennan SV; Kelly DJ; Schache M; Waltham M; Dy V; Langham RG; Yue DK; Gilbert RE
    Kidney Int; 2007 Aug; 72(4):481-8. PubMed ID: 17554258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular hypertrophy in experimental diabetes. Role of advanced glycation end products.
    Rumble JR; Cooper ME; Soulis T; Cox A; Wu L; Youssef S; Jasik M; Jerums G; Gilbert RE
    J Clin Invest; 1997 Mar; 99(5):1016-27. PubMed ID: 9062360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.